Open Access Open Access  Restricted Access Subscription Access

A Cross-Sectional Study on Quality of Life in Diabetes Mellitus (Type-2) Patients with Other Comorbid Conditions

Mallela Maharshi, Shuaib Yunus Mohammed, Thanati Joel Nathan, Panthagani Vidya, Nani Deepa, T.P.S Navya Krishna, Gali Deevena Priya

Abstract


Diabetes mellitus type-2 is a long-lasting non-communicable disease characterized by persistent hyperglycemia. A major patient-reported outcome is quality of life. The importance of achieving and maintaining a high quality of life is becoming increasingly recognized and expressed in diabetes advice, and it is an important health-care objective. Diabetes patients have a decreased quality of life (QOL) and are affected in almost every aspect of daily life, with this study, “We have observed that diabetes, diabetes with Cancer and thyroid are having a better quality of life when compared to other conditions”.


Full Text:

PDF

References


Trikkalinou A, Papazafiropoulou AK, Melidonis A. Type 2 diabetes and quality of life. World J Diabetes. 2017;8(4):120-9.

The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med. 1998;46:1569- 85.

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183- 97.

Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, etal. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160- 7.

International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-34.

Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ. Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med. 2004;19:1175- 80.

Sato KK, Hayashi T, Harita N, Yoneda T, Nakamura Y, Endo G, et al. Combined measurement of fasting plasmaglucoseandA1Ciseffectivefor the prediction of type 2 diabetes: the Kansai Healthcare Study. Diabetes Care. 2009;32:644-6.

Shimazaki T, Kadowaki T, Ohyama Y, Ohe K, Kubota K. Hemoglobin A1c (HbA1c) predicts future drug treatment for diabetes mellitus: a follow-up study using routine clinical data in a Japanese university hospital. Translational Research. 2007;149:196-204.

Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM. Changes in incidence of diabetes in U.S. adults, 1997–2003.AmJPrevMed.

;30:371-7.

Rose M, Fliege H, Hildebrandt M, Schirop T, Klapp BF. The network of psychological variables in patients with diabetes and their importance for quality of life and metabolic control. Diabetes Care. 2002;25:35-42.


Refbacks

  • There are currently no refbacks.